BioLineRx Ltd. (ADR)
General ticker "BLRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $307.5M (TTM average)
BioLineRx Ltd. (ADR) follows the US Stock Market performance with the rate: 4.4%.
Estimated limits based on current volatility of 3.9%: low 3.16$, high 3.42$
Factors to consider:
- Total employees count: 52 as of 2011
- Current price 32.0% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.79$, 15.38$]
- 2025-12-31 to 2026-12-31 estimated range: [3.47$, 10.65$]
Financial Metrics affecting the BLRX estimates:
- Positive: with PPE of 2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.41 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 34.60 <= 41.86
- Positive: Investing cash flow per share per price, % of 4.29 > -0.66
- Negative: negative Net income
Short-term BLRX quotes
Long-term BLRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $4.80MM | $28.94MM |
| Operating Expenses | $29.16MM | $54.49MM | $49.35MM |
| Operating Income | $-29.16MM | $-49.69MM | $-20.41MM |
| Non-Operating Income | $4.21MM | $-10.92MM | $11.19MM |
| Interest Expense | $2.16MM | $2.17MM | $9.07MM |
| R&D Expense | $17.63MM | $12.52MM | $9.15MM |
| Income(Loss) | $-24.95MM | $-60.61MM | $-9.22MM |
| Profit(Loss)* | $-24.95MM | $-60.61MM | $-9.22MM |
| Stockholders Equity | $50.84MM | $13.22MM | $13.46MM |
| Inventory | $0.20MM | $1.95MM | $3.15MM |
| Assets | $76.38MM | $63.92MM | $38.91MM |
| Operating Cash Flow | $-26.24MM | $-22.61MM | $-43.87MM |
| Capital expenditure | $0.32MM | $0.30MM | $0.05MM |
| Investing Cash Flow | $4.01MM | $1.44MM | $29.37MM |
| Financing Cash Flow | $20.44MM | $15.06MM | $20.66MM |
| Earnings Per Share** | $-0.48 | $-0.94 | $-0.12 |
| Ordinary share to ADR | 0.00x | 0.00x | 0.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.